Lori W. Barrentine

Association of Obesity and Inflammatory Marker Levels on Treatment Outcome

Richard C. Shelton, Michael Pencina, Lori W. Barrentine et al. · The Journal of Clinical Psychiatry · 2015 · 55 citations

Pharmacy, Pharmacotherapy, Psychiatry +16

Assessing Effects of <span style="font-variant:small-caps; ">l</span>-Methylfolate in Depression Management

Richard C. Shelton, J. Sloan Manning, Lori W. Barrentine et al. · The Primary Care Companion For CNS Disorders · 2013 · 36 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Long-Term Efficacy, Safety, and Tolerability of <span style="font-variant:small-caps; "> l</span>-Methylfolate Calcium 15 mg as Adjunctive Therapy With Selective Serotonin Reuptake Inhibitors

John Zajecka, Maurizio Fava, Richard C. Shelton et al. · The Journal of Clinical Psychiatry · 2016 · 29 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

CerefolinNAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer’s Disease and Cerebrovascular Disease

William R. Shankle, Junko Hara, Lori W. Barrentine et al. · Journal of Alzheimer s Disease · 2016 · 27 citations · Full text

Life Sciences, Neurology, Neuroscience +16

Nutritional management of patients with diabetic peripheral neuropathy with L-methylfolate-methylcobalamin-pyridoxal-5-phosphate: results of a real-world patient experience trial

Bruce S. Trippe, Lori W. Barrentine, Melanie V. Curole et al. · Current Medical Research and Opinion · 2015 · 24 citations · Full text

Agriculture, Nutrition, Pharmacotherapy +17